Actively Recruiting
Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma
Led by Select Eye Care · Updated on 2025-08-29
60
Participants Needed
1
Research Sites
63 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to to evaluate how well Direct Selective Laser Trabeculoplasty (DSLT) lowers eye pressure in eyes of adult, non-Caucasian participants with primary open angle glaucoma. The main question it aims to answer is: What is the washed out eye pressure (eye pressure when not on any glaucoma medications) of participants 6 months after the Direct Selective Laser Trabeculoplasty (DSLT) procedure compared to the washed out eye pressure of participants prior to the DSLT procedure. Participants will: Undergo the DSLT procedure in one or both eyes and visit the clinic 1 month, 3 months, and 6 months after the procedure to have their vision and eye pressure measured.
CONDITIONS
Official Title
Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Eye Pressure in Non-Caucasian Patients With Open Angle Glaucoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients of Black African descent scheduled to undergo DSLT treatment in one or both eyes
- Diagnosis of mild to moderate primary open angle glaucoma (POAG)
- Mild to moderate POAG defined as Stage 2 or better of the Hodapp-Anderson-Parrish glaucoma staging system
- Treatment naive or washed out intraocular pressure (IOP) at time 0 ranging from 63; 21 through 32 mm Hg
You will not qualify if you...
- Patients on IOP-lowering medications who did not successfully complete medication washout at the time of the procedure
- Patients who have undergone prior glaucoma-related procedures such as trabeculectomy, laser trabeculoplasty, MIGS, or tube shunt
- Patients with secondary forms of glaucoma including angle-closure glaucoma, neovascular glaucoma, or glaucoma from trauma or systemic diseases
- Patients with other significant eye conditions like advanced cataracts or retinal diseases that complicate IOP or vision assessment
- Pregnant, breastfeeding, or intending to become pregnant during the study period
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Select Eye Care
Elkridge, Maryland, United States, 21075
Actively Recruiting
Research Team
S
Scott E LaBorwit, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here